Treatment for Migraines With an Implantable Device
Completed · Not applicable
Conditions studied: Migraine
In brief
The purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.
Key facts
- Study ID
- NCT00286078
- Run by
- Boston Scientific Corporation
- People needed
- 179
- Starts
- 2006-02-01
- Expected to finish
- 2018-11-07
- Last updated by the study team
- 2019-07-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mile High Research Center — Denver, Colorado, United States
- The New England Center for Headache — Stamford, Connecticut, United States
- Walton Rehabilitation Hospital — Augusta, Georgia, United States
- Rush Pain Center — Chicago, Illinois, United States
- Diamond Headache Clinic — Chicago, Illinois, United States
- New England Regional Headache Center — Worcester, Massachusetts, United States
- Headache Care Center — Springfield, Missouri, United States
- Headache Specialists — Las Vegas, Nevada, United States
- Albert Einstein College of Medicine - Montefiore Headache Unit — The Bronx, New York, United States
- The Neurological Clinic — Portland, Oregon, United States
- Thomas Jefferson University - Jefferson Headache — Philadelphia, Pennsylvania, United States
- Nashville Neuroscience Group — Nashville, Tennessee, United States
- Research Center — Fort Worth, Texas, United States
- Lifetree Clinical Research — Salt Lake City, Utah, United States
- Swedish Pain & Headache Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.